Medicare, Medicaid Rx Price Reporting Are IG Review Priorities For 2005
This article was originally published in The Pink Sheet Daily
Executive Summary
The HHS Inspector General will conduct several reviews related to drug manufacturers' price reporting for Medicare and Medicaid, IG's fiscal 2005 work plan says